2010 Fiscal Year Final Research Report
BRAK is a new type marker for development of tailor made medicine in head and neck squamous cell carcinoma.
Project/Area Number |
21792037
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Surgical dentistry
|
Research Institution | Kanagawa Dental College |
Principal Investigator |
OZAWA Shigeyuki Kanagawa Dental College, 歯学部, 助教 (40434394)
|
Project Period (FY) |
2009 – 2010
|
Keywords | ケモカイン / BRAK / 扁平上皮癌 |
Research Abstract |
BRAK is not expressed or negligible level in head and neck squamous cell carcinoma. We cleared that methylation of BRAK promoter regulates the expression of BRAK as a negative regulator.
|
-
-
-
-
-
-
-
-
[Journal Article] Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.2009
Author(s)
Ozawa S, Kato Y, Ito S, Komori R, Shiiki N, Tsukinoki K, Ozono S, Maehata Y, Taguchi T, Imagawa-Ishiguro Y, Tsukuda M, Kubota E, Hata R.
-
Journal Title
Cancer Sol. 100(11)
Pages: 2202-2209
Peer Reviewed
-
-
-
-
-
-
-
-
-
[Presentation] A new mechanism of tumor suppression by gefitinib in HNSCC.2009
Author(s)
Shigeyuki Ozawa, Yasumasa Kato, Shin Ito, Reika Komori, Naoto Shiiki, Keiichi Tukinoki, Satoru Ozono, Yojiro Maehata, Takahide Taguchi, Yukari Imagawa-Ishiguro, Mamoru Tsukuda, Eiro Kubota, Ryu-Ichiro Hata
Organizer
87^<th> General Session & Exhibition of the IADR・38^<th> Annual Meeting of the AADR・33^<rd> Annual Meeting of the CADR
Place of Presentation
Miami Beach Convention Center, Miami, Florida
Year and Date
20090401-20090404
-
-
[Presentation] Chemokine BRAK stimulates apoptosis elicited by gefitinib in oral squamous cell carcinoma2009
Author(s)
Shin Ito, Shigeyuki Ozawa, Naoto Shiiki, Keiichi Tsukinoki, Eiro Kubota, Yasumasa Kato, Takahide Taguchi, Yukari Imagawa-Ishiguro, Mamoru Tsukuda, Ryu-Ichiro Hata
Organizer
Yokosuka Science Festa
Place of Presentation
Shonan Village Center, Hayama
Year and Date
2009-07-06
-
[Presentation] Expression of BRAK/CXCL14 is associated with antitumor efficacy of gefitinib in head and neck squamous cell carcinoma.2009
Author(s)
Shigeyuki Ozawa, Yasumasa Kato, Shin Ito, Reika Komori, Kenji Suzuki, Keiichi Tsukinoki, Yojiro Maehata, Takahide Taguchi, Yukari Imagawa-Ishiguro, Mamoru Tsukuda, Eiro Kubota, Ryu-Ichiro Hata
Organizer
Yokosuka Science Festa
Place of Presentation
Shonan Village Center, Hayama
Year and Date
2009-07-06
-
-